Boston Scientific Corporation (BSX)

Boston Scientific Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-	1,854	1,593	698	1,041	-82
Depreciation & Amortization	-	1,269	1,196	1,136	1,093	1,123
Loss (Gain) From Sale of Assets	-	-	-	22	-78	-
Asset Writedown & Restructuring Costs	-	386	58	132	370	533
Loss (Gain) From Sale of Investments	-	79	59	1	-250	-333
Stock-Based Compensation	-	266	233	220	194	170
Other Operating Activities	-	43	134	322	-149	120
Change in Accounts Receivable	-	-351	-238	-220	-279	335
Change in Inventory	-	-228	-660	-321	-346	-65
Change in Accounts Payable	-	243	118	-255	408	-28
Change in Other Net Operating Assets	-	-126	10	-209	-134	-265
Operating Cash Flow	-	3,435	2,503	1,526	1,870	1,508
Operating Cash Flow Growth	-	37.23%	64.02%	-18.40%	24.01%	-17.87%
Capital Expenditures	-	-790	-711	-588	-554	-376
Sale of Property, Plant & Equipment	-	3	4	12	14	12
Cash Acquisitions	-	-4,640	-1,811	-1,542	-2,258	-3
Divestitures	-	-	-	5	826	15
Sale (Purchase) of Intangibles	-	20	30	70	82	87
Investment in Securities	-	-280	-89	-24	279	-146
Other Investing Activities	-	-	3	56	14	-
Investing Cash Flow	-	-5,687	-2,574	-2,011	-1,597	-411
Short-Term Debt Issued	-	211	-	-	-	4,161
Long-Term Debt Issued	-	2,145	-	3,270	-	1,683
Total Debt Issued	-	2,356	-	3,270	-	5,844
Short-Term Debt Repaid	-	-504	-4	-251	-	-5,583
Long-Term Debt Repaid	-	-25	-	-3,184	-	-1,260
Total Debt Repaid	-	-529	-4	-3,435	-	-6,843
Net Debt Issued (Repaid)	-	1,827	-4	-165	-	-999
Issuance of Common Stock	-	230	182	136	110	1,086
Repurchase of Common Stock	-	-87	-56	-53	-	-535
Preferred Dividends Paid	-	-	-28	-55	-55	-28
Dividends Paid	-	-	-28	-55	-55	-28
Other Financing Activities	-	-156	-89	-411	-150	-206
Financing Cash Flow	-	1,814	5	-548	-95	293
Foreign Exchange Rate Adjustments	-	-11	-4	-9	-6	-2
Miscellaneous Cash Flow Adjustments	-	-1	-	-	1	-
Net Cash Flow	-	-450	-70	-1,042	173	1,388
Free Cash Flow	-	2,645	1,792	938	1,316	1,132
Free Cash Flow Growth	-	47.60%	91.05%	-28.72%	16.25%	-17.67%
Free Cash Flow Margin	-	15.79%	12.58%	7.40%	11.07%	11.42%
Free Cash Flow Per Share	-	1.78	1.22	0.65	0.92	0.80
Cash Interest Paid	-	250	259	450	338	359
Cash Income Tax Paid	-	656	512	662	302	207
Levered Free Cash Flow	-	1,808	1,880	1,155	2,654	1,110
Unlevered Free Cash Flow	-	1,998	2,046	1,449	2,867	1,336
Change in Net Working Capital	-	643	213	660	-912	263

Updated Jul 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q